lamivudine has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, S; Ikeda, H; Iwasaki, Y; Kobashi, H; Miyake, Y; Sakaguchi, K; Shiratori, Y; Takaguchi, K; Takaki, A | 1 |
1 other study(ies) available for lamivudine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Lamivudine treatment improves the prognosis of fulminant hepatitis B.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome | 2008 |